BeautyHealth Appoints Philippe Schaison to Board of Directors

BeautyHealth appoints Philippe Schaison, a global aesthetics leader, to its Board of Directors effective October 30, 2025.

Quiver AI Summary

The BeautyHealth Company has appointed Philippe Schaison, a seasoned leader in global aesthetics, biotech, and consumer health, to its Board of Directors, effective October 30, 2025. With over 20 years of experience, Dr. Schaison is currently the CEO of Soltégo, Inc. and has previously held prominent positions at Syneron Candela and Allergan Aesthetics. He brings significant expertise and a strong track record of driving innovation and profitability in the beauty industry. Brent Saunders, Executive Chairman of BeautyHealth, highlighted that Dr. Schaison's skills will enhance the company's growth potential and global reach, especially for its Hydrafacial brand. Following his appointment, the Board will consist of eight directors, with Dr. Schaison also taking roles on the Compensation and Nominating & Corporate Governance Committees.

Potential Positives

Appointment of Philippe Schaison to the Board enhances the company's leadership with a proven expert in global aesthetics and biotech sectors.
Dr. Schaison's background in scaling beauty businesses is expected to unlock the full potential of the Hydrafacial brand.
The addition of Dr. Schaison to the Board is anticipated to accelerate growth and innovation within the company.

Potential Negatives

Appointment of Dr. Philippe Schaison may indicate previous board vacancies or lack of internal talent, raising questions about succession planning and internal leadership development.
The reliance on external leadership talent like Dr. Schaison could suggest a need for significant strategic shifts, which may create uncertainty among stakeholders regarding the company's future direction.
The announcement does not provide details on the performance metrics or changes expected from Dr. Schaison's appointment, which could lead to skepticism about the effectiveness of the decision.

FAQ

Who is Philippe Schaison?

Philippe Schaison is a global aesthetics leader appointed to the BeautyHealth Board, effective October 30, 2025.

What roles has Dr. Schaison held in the past?

Dr. Schaison has served as CEO at Syneron Candela, and Allergan Aesthetics, and held leadership roles at companies like Johnson & Johnson.

What are Dr. Schaison's qualifications?

He holds an M.B.A. from Hautes Etudes Commerciales in Paris and a Doctorate in Pharmacy from Université Paris V René Descartes.

What contributions is Dr. Schaison expected to make?

His experience is anticipated to help enhance the Hydrafacial brand and accelerate growth for BeautyHealth.

How many directors are on the BeautyHealth Board now?

Following Dr. Schaison's appointment, BeautyHealth's Board will consist of eight directors.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$SKIN Hedge Fund Activity

We have seen 53 institutional investors add shares of $SKIN stock to their portfolio, and 41 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JANUS HENDERSON GROUP PLC removed 2,575,163 shares (-31.0%) from their portfolio in Q2 2025, for an estimated $4,918,561
BLACKROCK, INC. added 1,709,743 shares (+30.8%) to their portfolio in Q2 2025, for an estimated $3,265,609
WOODLINE PARTNERS LP added 1,666,030 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,182,117
SOLEUS CAPITAL MANAGEMENT, L.P. added 1,000,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,910,000
MIRABELLA FINANCIAL SERVICES LLP added 614,602 shares (+5.0%) to their portfolio in Q2 2025, for an estimated $1,173,889
GEODE CAPITAL MANAGEMENT, LLC added 496,963 shares (+27.5%) to their portfolio in Q2 2025, for an estimated $949,199
UBS GROUP AG removed 480,136 shares (-61.2%) from their portfolio in Q2 2025, for an estimated $917,059

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$SKIN Price Targets

Multiple analysts have issued price targets for $SKIN recently. We have seen 2 analysts offer price targets for $SKIN in the last 6 months, with a median target of $3.0.

Here are some recent targets:

Oliver Chen from TD Cowen set a target price of $2.5 on 09/22/2025
George Kelly from Roth Capital set a target price of $3.5 on 09/19/2025

Full Release

LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025.

Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L’Oréal. Today, Dr. Schaison serves as Chairman of the Board of Raziel Therapeutics Ltd., an Israeli-based biotechnology company, and sits on a number of other biomedical company boards including AIVITA Biomedical, Inc., Dyve Biosciences, Inc., and miraDry, Inc. Dr. Schaison earned an M.B.A. from Hautes Etudes Commerciales in Paris, and a Doctorate in Pharmacy from the Université Paris V René Descartes.

BeautyHealth Executive Chairman Brent Saunders said: “Philippe’s experience scaling global beauty and aesthetics businesses, coupled with his proven ability to drive innovation and profitability, will bring invaluable perspective to the BeautyHealth Board. His deep expertise will help the Company unlock the full potential of the dynamic Hydrafacial brand, elevate our global reach, and accelerate category growth.”

Dr. Schaison fills an open seat on the BeautyHealth Board and will join the Compensation and Nominating & Corporate Governance Committees. Following the appointment, BeautyHealth’s Board will be comprised of eight directors.

About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn .

Contacts:
Investors: [email protected]
Media: [email protected]

Source: BeautyHealth

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e88819a-f590-4e51-a7fe-66872a55b5ef